
Lacticodeshydrogénase (LDH) and Ferrétinémia, Biomarkers of Coronavirus disease (COVID-19)
Author(s) -
Nawal Brikci Nigassa,
Mustapha Haddouche
Publication year - 2020
Publication title -
international journal of infectious diseases and research
Language(s) - English
Resource type - Journals
ISSN - 2693-2326
DOI - 10.47485/2693-2326.1005
Subject(s) - covid-19 , coronavirus , disease , medicine , virology , nose , respiratory tract , infectious disease (medical specialty) , respiratory system , pathology , outbreak , anatomy
Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern [1-2]. Its involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVID-19). This pathogenic virus has been identified in swabs performed on the throat and nose of patients who suffer from or are suspected of the disease [1]. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19 [2].